Emestedastat

An investigational drug for cancer treatment

Emestedastat
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Emestedastat is an investigational drug that is being studied for its potential use in the treatment of various types of cancer. It is a small molecule inhibitor that targets a specific enzyme involved in cancer cell metabolism.

Mechanism of Action

Emestedastat functions as an inhibitor of the enzyme histone demethylase, specifically targeting the lysine-specific demethylase 1 (LSD1). LSD1 is an enzyme that plays a crucial role in the regulation of gene expression by demethylating histone proteins, which are essential components of chromatin structure. By inhibiting LSD1, emestedastat can alter the expression of genes involved in cancer cell proliferation and survival.

Clinical Development

Emestedastat is currently undergoing clinical trials to evaluate its safety and efficacy in patients with various types of cancer, including acute myeloid leukemia (AML) and small cell lung cancer (SCLC). These trials aim to determine the optimal dosing regimen and to assess the drug's potential as a monotherapy or in combination with other anticancer agents.

Pharmacokinetics

The pharmacokinetic profile of emestedastat is characterized by its absorption, distribution, metabolism, and excretion properties. Studies have shown that emestedastat is well-absorbed when administered orally, and it exhibits a favorable distribution profile, allowing it to reach target tissues effectively. The metabolism of emestedastat involves hepatic pathways, and it is primarily excreted through the renal system.

Potential Side Effects

As with many investigational drugs, emestedastat may cause side effects. Commonly observed adverse effects in clinical trials include fatigue, nausea, and hematological abnormalities such as thrombocytopenia and neutropenia. Ongoing studies continue to monitor the safety profile of emestedastat to better understand its risk-benefit ratio.

Research and Future Directions

Research on emestedastat is focused on understanding its full therapeutic potential and identifying biomarkers that can predict patient response. Future studies may explore its use in combination with other targeted therapies or immunotherapy to enhance its anticancer effects. Additionally, research is ongoing to investigate its role in other malignancies beyond AML and SCLC.

Related Pages

• Cancer treatment
• Histone demethylase
• Acute myeloid leukemia
• Small cell lung cancer